Society guideline links: Myeloproliferative neoplasms

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●World Health Organization (WHO): Classification and diagnostic criteria for myeloproliferative neoplasms – Document summary and in-depth discussion, 2016 (published 2018)

Europe

●European Group for Blood and Marrow Transplantation (EBMT): Best practice recommendations for allogeneic haematopoietic cell transplantation for myelofibrosis – Proposed definitions and management strategies for graft failure, poor graft function and relapse (2021)

●European LeukemiaNet (ELN): Revised management recommendations on Philadelphia chromosome-negative classical myeloproliferative neoplasms (2018)

●EBMT and ELN: A consensus process for the indication and management of allogeneic stem cell transplantation in primary myelofibrosis (2015)

●European Society for Medical Oncology (ESMO): Clinical practice guidelines on Philadelphia chromosome-negative chronic myeloproliferative neoplasms (2015)

United Kingdom

●British Society for Haematology (BSH): Good practice paper on the use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders (2021)

●BSH: A guideline for the diagnosis and management of polycythaemia vera (2018)

●British Committee for Standards in Haematology (BCSH): Use of JAK inhibitors in the management of myelofibrosis – A revision of the guidelines for investigation and management of myelofibrosis, 2012 (published 2014)

Japan

●Japanese Society of Hematology (JSH): Guideline for tumors of hematopoietic and lymphoid tissues – Leukemia: Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN) (2017)